ReviewAnnals of the rheumatic diseases2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.
Review in Annals of the rheumatic diseases, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 50 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Etanercept for the treatment of rheumatoid arthritis.The Cochrane database of systematic reviews · 2013Pooled it
- Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity.Arthritis research & therapy · 2012Trial
- Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial.Annals of the rheumatic diseases · 2012Trial
- Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions.Annals of the rheumatic diseases · 2010Trial
- Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.Annals of the rheumatic diseases · 2009Trial
- A Stable CHO K1 Cell Line for Producing Recombinant Monoclonal Antibody Against TNF-α.Molecular biotechnology · 2021Article
- Development of Prediction Models for New Integrated Models and a Bioscore System to Identify Bacterial Infections in Systemic Lupus Erythematosus.Frontiers in cellular and infection microbiology · 2021Article
- Evaluation of the Efficacy of Combined Therapy of Methotrexate and Etanercept versus Methotrexate as a Mono-Therapy.Open access Macedonian journal of medical sciences · 2018Article
- Clinical Utility of Neutrophil CD64 to Detect Extrapulmonary Tuberculosis in Three Patients with Rheumatoid Arthritis Undergoing Treatment with Biologics.Case reports in rheumatology · 2018Article
- Pulmonary Tuberculosis.Microbiology spectrum · 2017Review
- Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line.SpringerPlus · 2016Article
- Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines.Rheumatology international · 2015Observational
- The contribution of natural selection to present-day susceptibility to chronic inflammatory and autoimmune disease.Current opinion in immunology · 2014Review
- Understanding the role of B cells in atherosclerosis: potential clinical implications.Expert review of clinical immunology · 2014Review
- A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.Dermatology and therapy · 2012Article
- Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists.Arthritis research & therapy · 2012Article
- Rituximab-based treatment, HCV replication, and hepatic flares.Clinical & developmental immunology · 2012Review
- Rheumatoid arthritis: refractory to infliximab, a tumor necrosis factor inhibitor.Journal of clinical medicine research · 2011Article
- Advances in the medical treatment of rheumatoid arthritis.Hand clinics · 2011Review
- Does rituximab increase the incidence of infectious complications? A narrative review.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2011Review
Corrections and comments
- Erratum issued
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.